All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 142 of 206 pages ‹ First  < 140 141 142 143 144 >  Last ›

HSL19993
Gebbie KM
Profitable Pills
AIDS Reader 2004;14:(106):109
http://www.medscape.com/viewarticle/472296

HSL20026
Jawaid SA, Jafary MH
Relationship between the medical profession and the pharma industry: Need for greater scrutiny, transparency and accountability
Pak J Med Sci 2004;20:(4):283-291
http://www.scribd.com/doc/31273862/Relationship-Between-the-Medical-Profession-AND-THE-PHARMA-INDUSTRY

HSL20190
Hochhauser M
Consumer-Friendly Patient Information Should Replace DTC Brief Summaries.
Product Management Today 2004;15:(1):26-28

HSL1549
Hughes G.
Drug giant linked to immunisation campaign
The Age 2003 Dec 22
http://www.theage.com.au/articles/2003/12/21/1071941610958.html

HSL195
McCarthy M.
NIH told to provide records in conflict of interest probe.
Lancet 2003 Dec 20;362:(9401):2076
http://web.archive.org/web/20041228074016/http://www.thelancet.com/journal/vol362/iss9401/abs/llan.362.9401.news.28183.1

HSL196
Sackett DL, Oxman AD; HARLOT plc.
HARLOT plc: an amalgamation of the world's two oldest professions.
BMJ 2003 Dec 20;327:(7429):1442-5
http://bmj.bmjjournals.com/cgi/content/full/327/7429/1442

HSL2161
Jefferson T, Shashok K, Wager E.
Get peered!
2003;327:(7429):1439-41
http://bmj.bmjjournals.com/cgi/content/full/327/7429/1439

HSL9887
Brocvielle H, Muret P, Plenat E, Kantelip JP, Humbert P.
Management of a patient receiving thalidomide
Presse Med. 2003 Dec 20;32:(40):1894-8
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=100&CodeRevue4=PM&Path=REVUE/PM/2003/32/40/ARTICLE1110875240.xml&Locations=

HSL18044
Burls A, Sandercock J.
How to make a compelling submission to NICE: tips for sponsoring organisations.
BMJ 2003 Dec 20;327:(7429):1446-8
http://www.bmj.com/cgi/pdf_extract/327/7429/1446

HSL20358
Currie C
Clinical arithmetic: An Enlightenment legacy still needs defending—against more subtle adversaries
BMJ 2003 Dec 20;327:(7429):
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC300788/

HSL1547
U-M study: Doctors more likely to prescribe pricey new blood pressure drugs: Free drug samples may influence doctors' choices, researcher suggests
University of Michigan Health System 2003 Dec 19

HSL1548
Agovino T.
Rough flu season highlights economic problems of vaccine industry
Canadian Press 2003 Dec 19

HSL13306
Richard O, Van Horn L.
Persistence in prescriptions of branded drugs
International Journal of Industrial Organization 2003 Dec 19;22:(4):523-540
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8P-4B8BST2-1&_user=10&_coverDate=04%2F30%2F2004&_rdoc=5&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235876%232004%23999779995%23490895%23FLA%23display%23Volume)&_cdi=5876&_sort=d&_docanchor=&_ct=9&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=f83412caf487e79e0bebbdd221ef44f4

HSL2
Komesaroff P.
Doctors, drugs and ethics
The Age 2003 Dec 18
http://www.theage.com.au/articles/2003/12/17/1071337024455.html?from=storyrhs

HSL3
Hughes G.
Drug firm linked to cancer group
The Age 2003 Dec 18

HSL1545
Baker B.
U.S.'s Misguided and Bad-Faith Attack on the WHO's 3-by-5 Plan
IP-Health 2003 Dec 18

HSL1546
Harris G.
States Try to Limit Drugs in Medicaid, but Makers Resist
New York Times 2003 Dec 18
http://www.nytimes.com/2003/12/18/business/states-try-to-limit-drugs-in-medicaid-but-makers-resist.html

HSL18045
Blumethal D
Academic–Industrial Relationships in the Life Sciences
NEJM 2003 Dec 18;349:(25):2452
http://intl-content.nejm.org/cgi/content/full/349/25/2452

HSL4
A different kind of drug problem
The Age 2003 Dec 17

HSL1542
Kolata G.
A Contraceptive Clears a Hurdle to Wider Access
The New York Times 2003 Dec 17
http://www.nytimes.com/2003/12/17/us/a-contraceptive-clears-a-hurdle-to-wider-access.html

HSL1543
Arbor A.
Drug company fees for FDA reviews haven't accelerated approvals, study finds: Study also fails to find evidence of approval bias favoring big drug companies
2003 Dec 17

HSL1544
World Medical Association Press Release: Urgent Need For New Drugs In Sub Saharan Africa, Says WMA President
2003 Dec 17

HSL6260
World Medical Association
Urgent need for new drugs in sub Saharan Africa, says WMA President
World Medical Association 2003 Dec 17
http://web.archive.org/web/20080511231653/http://www.wma.net/e/press/2003_24.htm

HSL19924
Lundberg GD
Uninvited, Unwelcome Medical Email Message
MedScape 2003 Dec 16;5:(4):
http://www.medscape.com/viewarticle/465734

HSL5
Hawaleskha D.
Viagra's New Competition: The little blue pill faces its rivals as men flock to boost their sex lives
McLeans.ca 2003 Dec 15

HSL6
Minchin L, Hughes G.
Push for action on drug firms
The Age 2003 Dec 15
http://www.theage.com.au/articles/2003/12/14/1071336810347.html?from=storyrhs

HSL1541
Elliott C.
Not-So-Public Relations: How the drug industry is branding itself with bioethics.
MSN Slate 2003 Dec 15
http://www.slate.com/id/2092442/

HSL1539
Gilpin K.
The Winners in the Medicare Bill, and Why
The New York Times 2003 Dec 14

HSL1536
Hughes G, Minchin L.
Drug giants' big-money pitch exposed
The Age 2003 Dec 13
http://www.theage.com.au/articles/2003/12/12/1071125659634.html?from=storyrhs

HSL1537
Hughes G.
Taking your medicine
The Age 2003 Dec 13
http://www.theage.com.au/articles/2003/12/12/1071125658355.html

HSL1538
Hughes G.
Drug firms fund disease awareness
Sydney Morning Herald 2003 Dec 13
http://www.smh.com.au/articles/2003/12/12/1071125652945.html

HSL7347
Ellner A.
Rethinking prescribing in the United States.
BMJ 2003 Dec 13;327:(7428):1397-400
http://www.bmj.com/cgi/content/full/327/7428/1397

HSL9890
Garattini S, Garattini L.
Drug sales in four European countries still differ.
BMJ 2003 Dec 13;327:(7428):1404-5
http://www.bmj.com/cgi/content/full/327/7428/1404-c

HSL18048
Dyer O
City reacts negatively as GlaxoSmithKline announces plans for new drugs
BMJ 2003 Dec 13;327:(7428):1366
http://www.bmj.com/cgi/reprint_abr/327/7428/1366

HSL18049
Gibson L
Medicines agency introduces greater transparency
BMJ 2003 Dec 13;327:(7428):1368
http://www.bmj.com/cgi/content/extract/327/7428/1368-d

HSL18050
Burton B
Australian government tries to stop independent advice on diabetes drugs
BMJ 2003 Dec 13;327:(7428):1368
http://www.bmj.com/cgi/content/extract/327/7428/1368-g

HSL1535
Some Consumer Ads for Aventis' Taxotere Misleading, U.S. FDA Charges
Reuters 2003 Dec 12

HSL1540
Bates D.
The Medicare Morass: Many seniors upset about changes to federal program
The News-Register 2003 Dec 12

HSL1533
Mahoney J.
Leading vitamin scientist faces fire over data
The Globe and Mail 2003 Dec 11

HSL1534
Bramham D.
Depressed Kids: The Drug Debate: Are the young used as guinea pigs for untested antidepressants?
Sterling News Service 2003 Dec 11

HSL7
Blumenstyk G.
2 Congressmen Take Aim at NIH Officials' Consulting Deals With Drug Companies
The Chronicle of Higher Education 2003 Dec 10

HSL1532
Boseley S.
Drugs for depressed children banned
The Guardian 2003 Dec 10
http://www.guardian.co.uk/science/2003/dec/10/drugs.sciencenews

HSL8
Dobade G
Drug price control: no relief for poor
Deccan Herald 2003 Dec 09

HSL1531
Willman D.
Records of Payments to NIH Staff Sought: Two congressmen ask health institutes' leader to detail researchers' links to drug companies.
LA Times 2003 Dec 9
http://articles.latimes.com/2003/dec/09/nation/na-nih9

HSL11630
Kauffman JM.
Statin Drugs: A Critical Review of the Risk/Benefit Clinical Research
Recoverymedicine.com 2003 Dec 9
http://www.recoverymedicine.com/cholesterol_lowering_drug_side_effects.htm

HSL1529
Connor S.
Glaxo chief: Our drugs do not work on most patients
Independent news 2003 Dec 8
http://www.independent.co.uk/news/science/glaxo-chief-our-drugs-do-not-work-on-most-patients-575942.html

HSL1527
Willman D.
Stealth Merger: Drug Companies and Government Medical Research
LA Times 2003 Dec 7
http://articles.latimes.com/2003/dec/07/nation/na-nih7

HSL1528
Barnett A.
Revealed: how drug firms 'hoodwink' medical journals: Pharmaceutical giants hire ghostwriters to produce articles - then put doctors' names on them
The Observer 2003 Dec 7

HSL44
Tesoriero H
Torrid Drug-Price Increases Pause AARP Reports 0.5% Rise On Average in 3rd Quarter; Steeper Gains May Loom
The Wall Street Journal 2003 Dec 6

HSL1526
Westphal S.
You're my wife?
New Scientist 2003 Dec 6
http://www.newscientist.com/article/mg18024241.500-youre-my-wife.html

HSL18052
Ahmad K.
USA-Morocco deal may extend drug patents to 30 years.
Lancet 2003 Dec 6;362:(9399):1904
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)15006-4

HSL1525
Fidelman C.
Druggists probed for illegal gifts: Order investigates. Kickbacks from pharmaceutical firms might have included loans, houses, trips
The Montreal Gazette 2003 Dec 5

HSL1522
Meikle J.
Ban for HRT in cancer warning: 'Wonder' drug no longer first choice for osteoporosis
The Guardian 2003 Dec 4
http://www.guardian.co.uk/uk/2003/dec/04/health.healthandwellbeing

HSL1523
Big Pharma:The benefits of hypertension: Growing pressure on pharmaceutical firms is a force for good
The Economist 2003 Dec 4

HSL1524
The drugs industry: Big trouble for Big Pharma: Why Big Pharma urgently needs a new business model
The Economist 2003 Dec 4

HSL9896
Zuger A.
Rx: Canadian drugs.
N Engl J Med 2003 Dec 4;349:(23):2188-90
http://content.nejm.org/cgi/content/extract/349/23/2188

HSL18051
Thomas CP.
Incentive-based formularies.
N Engl J Med 2003 Dec 4;349:(23):2186-8
http://content.nejm.org/cgi/content/extract/349/23/2186

HSL1521
Mathews A.
Federal Agencies Seek to Curb Abuse of Potent Painkillers
The Wall Street Journal 2003 Dec 3

HSL9
Promotion disguised as research
The Gazette 2003 Dec 2

HSL1519
Callahan P.
Lilly's Zyprexa Acted Similarly To Cheaper Drug
The Wall Street Journal 2003 Dec 2

HSL1520
Lerner S.
Medical Students Go Beyond Books to Learn About Activism
New York Times 2003 Dec 2
http://www.nytimes.com/2003/12/02/health/02EDUC.html

HSL1189
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15;179:(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html

HSL1248
Baena Diez JM, Lopez Mompo C, Lopez Gosp D, Martinez Martinez JL, Ellacuria Torres A, Fuentes Rodriguez S.
[Good morning, Mr. Representative. Anything new to tell us about? Analysis of the pharmacological products introduced by the drugs industry into a health district]
Aten Primaria 2003 Dec 01;32:(10):557-61
http://www.ncbi.nlm.nih.gov/pubmed/14697177

HSL1250
Antonuccio DO, Danton WG, McClanahan TM.
Psychology in the prescription era: building a firewall between marketing and science.
Am Psychol 2003 Dec 01;58:(12):1028-43
http://content.apa.org/journals/amp/58/12/1028

HSL1516
Spears T.
Drug companies get doctors to endorse tainted medical research
Victoria Times 2003 Dec 1

HSL1517
Court Declines Patent Case Over 'Off-Label' Drug Uses
Wall Street Journal 2003 Dec 1

HSL1518
Guyatt G.
Beware of phony citizens' groups sponsored by drug companies: Patient advocacy groups are often not what they seem
2003 Dec 1

HSL1837
Mur E, Hartig F, Blumenthal-Hausmann E, Falkenbach A.
[Quality assurance in the teaching of medical students illustrated by the example of spa therapy for rheumatic diseases] .
Forsch Komplementarmed Klass Naturheilkd 2003 Dec 01;10:(6):298-302
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=FKM2003010006298

HSL1902
Rutledge P, Crookes D, McKinstry B, Maxwell SR.
Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
Pharmacoepidemiol Drug Saf. 2003 Dec 01;12:(8):663-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14762982&query_hl=3

HSL5754
Warner TD, Gluck JP.
What do we really know about conflicts of interest in biomedical research?
Psychopharmacology (Berl) 2003 Dec 01;171:(1):36-46
http://www.springerlink.com/(13h2cx45krkzla45np3myu45)/app/home/contribution.asp?referrer=parent&backto=issue,6,17;journal,62,719;linkingpublicationresults,1:100390,1

HSL7563
Young D.
FDA examines direct-to-consumer advertising data.
Am J Health Syst Pharm 2003 Dec 1;60:(23):2420,
http://www.ajhp.org/cgi/reprint/60/23/2420

HSL11443
Coote W.
There is such a thing as a free lunch?
Med J Aust 2003 Dec 1-15;179:(11-12):672
http://www.mja.com.au/public/issues/179_11_011203/coote_letter_011203.html

HSL18047
Ooi ES, Chapman S.
An analysis of newspaper reports of cancer breakthroughs: hope or hype?
Med J Aust 2003 Dec 1-15;179:(11-12):639-43
http://www.ncbi.nlm.nih.gov/pubmed/14636141

HSL1202
Katz A.
Observations and advertising: controversies in the prescribing of hormone replacement therapy
Health Care Women Int 2003 Dec;24:(10):927-39

HSL1206
Hildebrandt M, Ludwig WD.
Clinical research and industrial sponsoring: avenues towards transparency and credibility.
Onkologie 2003 Dec;26:(6):529-34
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=ONK2003026006529

HSL1247
Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW.
Quantitative analysis of sponsorship bias in economic studies of antidepressants.
Br J Psychiatry 2003 Dec;183:498-506:
http://bjp.rcpsych.org/cgi/content/full/183/6/498

HSL9883
Votano J.
The high cost of adverse drug reactions
Current Drug Discovery 2003 Dec;9-10

HSL10286
Horikoshi A, Takei K, Sawada S.
Effects of lower dose of imatinib to CML patients.
Leuk Res 2003 Dec;27:(12):1167
http://linkinghub.elsevier.com/retrieve/pii/S0145212603001012

HSL858
Jureidini J, Mansfield P, Menkes D.
The statin wars.
Lancet 2003 Nov 29;362:(9398):1855

HSL18054
Burton B
Drug companies succeed in keeping payments to doctors secret
BMJ 2003 Nov 29;327:(7426):1248
http://www.bmj.com/cgi/content/extract/327/7426/1248-a

HSL18055
Webster P
FDA chief attacks Canada's drug price controls.
Lancet 2003 Nov 29;362:(9398):1816
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)14949-5

HSL18056
Tite L
Drug company pushes for all children under 2 to be vaccinated against pneumonia
BMJ 2003 Nov 29;327:(7426):1249
http://www.bmj.com/cgi/content/extract/327/7426/1249-a

HSL1495
Marcus A.
Superiority of New Schizophrenia Drug Challenged
HealthDayNews 2003 Nov 25

HSL18053
Gandey A
Bupropion: 1 drug, 4 different brand names
CMAJ 2003 Nov 25;169:(11):1202
http://www.cmaj.ca/cgi/content/full/169/11/1202

HSL18057
Moynihan R.
Should drug companies be allowed to sponsor Cochrane reviews?
CMAJ 2003 Nov 25;169:(11):1201
http://www.cmaj.ca/cgi/content/full/169/11/1201

HSL1492
Branswell H.
Group that advises doctors on preventive health care loses funding, must fold
Canadian Press 2003 Nov 24

HSL1493
Goldstein A.
Medicare Bill Would Enrich Companies: Hundreds of Billions for Employers, Health Firms
Washington Post Staff 2003 Nov 24

HSL1494
Landers P.
With Dry Pipelines, Big Drug Makers Stock Up in Japan: Shunning High-Tech Gizmos, The Asian Scientists Score With Traditional Lab Work
Wall Street Journal 2003 Nov 24

HSL1490
Mercola J.
World's Largest Media Source Controlled by World's Largest Drug Company
Mercola.com 2003 Nov 23

HSL1491
Hall S.
Quest for hot new drugs spikes costs: High failure rate, time they take to develop hurt companies
The Detroit News 2003 Nov 23

HSL9927
de Haan GJ, Carpay JA, van Donselaar CA.
Antiepileptic primidone shortly to be withdrawn from sale: change medication now.
Ned Tijdschr Geneeskd 2003 Nov 22;147:(47):2325-6

HSL18058
Garattini S, Bertele' V, Li Bassi L.
European Council waters down European Parliament's drug-regulatory legislation.
Lancet 2003 Nov 22;362:(9397):1688-9
http://linkinghub.elsevier.com/retrieve/pii/S0140673603148829

HSL18059
Aronson JK, Ferner RE.
Joining the DoTS: new approach to classifying adverse drug reactions.
BMJ 2003 Nov 22;327:(7425):1222-5
http://www.bmj.com/cgi/content/full/327/7425/1222?view=long&pmid=14630763

HSL5850
Toop L.
Last time around for DTCA
N Z Med J. 2003 Nov 21;116:(1186):U693

HSL1488
Hallam K.
Merck Leads Industry in Spending to Lobby on Medicare
Bloomberg News 2003 Nov 20

HSL1489
Walker B, Sucher L.
Chemical Industry's Secret Plan to Attack California's Anti-toxics trend: Memo Calls for Phony Front Groups, Spying on Activists
Environmental Working Group 2003 Nov 20

HSL10
Wilde Mathews A, Steinberg B
FTC Examines Health Claims In KFC's Ads
The Wall Street Journal 2003 Nov 19
http://traynota.blogspot.com/

HSL11
Greenhouse S.
Capping the Cost of Atrocity: Survivor of Nazi Experiments Says $8,000 Isn't Enough
The New York Times 2003 Nov 19
http://www.nytimes.com/2003/11/19/nyregion/capping-the-cost-of-atrocity-survivor-of-nazi-experiments-says-8000-isn-t-enough.html?pagewanted=1?pagewanted=1

HSL1486
Simon B.
Canada Rebuffs U.S. on Prescription Drugs
The New York Times 2003 Nov 19
http://www.nytimes.com/2003/11/19/business/canada-rebuffs-us-on-prescription-drugs.html

HSL1487
Hallam K.
Calpers Opposes Medicare Compromise, Asks for Subsidy
Bloomberg News 2003 Nov 19

Page 142 of 206 pages ‹ First  < 140 141 142 143 144 >  Last ›